BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 46 filers reported holding BIOTA PHARMACEUTIALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,101,000 | +97.7% | 734,226 | +155.7% | 0.00% | – |
| Q4 2015 | $557,000 | -99.7% | 287,119 | -94.4% | 0.00% | -100.0% |
| Q3 2015 | $174,340,000 | +31256.1% | 5,102,781 | +1799.8% | 0.01% | – |
| Q2 2015 | $556,000 | -8.4% | 268,594 | +1.8% | 0.00% | – |
| Q1 2015 | $607,000 | +25.7% | 263,928 | +22.3% | 0.00% | – |
| Q4 2014 | $483,000 | -2.0% | 215,876 | +8.1% | 0.00% | – |
| Q3 2014 | $493,000 | -3.9% | 199,781 | +11.0% | 0.00% | – |
| Q2 2014 | $513,000 | -19.5% | 179,977 | +72.7% | 0.00% | – |
| Q1 2014 | $637,000 | +308.3% | 104,220 | +181.1% | 0.00% | – |
| Q4 2013 | $156,000 | -46.2% | 37,075 | -46.4% | 0.00% | – |
| Q3 2013 | $290,000 | +25.0% | 69,234 | +3.2% | 0.00% | – |
| Q2 2013 | $232,000 | – | 67,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 729,781 | $2,080,000 | 1.97% |
| Healthcare Value Capital, LLC | 145,507 | $415,000 | 0.35% |
| Broadfin Capital, LLC | 2,244,266 | $6,396,000 | 0.32% |
| TOWERVIEW LLC | 225,000 | $641,000,000 | 0.31% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 360,668 | $1,028,000 | 0.22% |
| Dominick & Dominick LLC | 146,016 | $416,000 | 0.20% |
| BVF INC/IL | 435,900 | $1,242,000 | 0.20% |
| Perceptive Advisors | 253,400 | $722,000 | 0.07% |
| BAILARD, INC. | 115,000 | $328,000 | 0.05% |
| KNOTT DAVID M | 88,100 | $251,085,000 | 0.04% |